Rational use management standards of national key monitoring drug
- VernacularTitle:国家重点监控药品合理用药管理规范
- Author:
Feifei XU
1
,
2
;
Yuan BIAN
1
,
2
;
Yong HAN
1
,
2
;
Junfeng YAN
1
,
2
;
Rongsheng TONG
1
Author Information
1. Dept. of Pharmacy，Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital，Chengdu 610072，China
2. Personalized Drug Therapy Key Laboratory of Sichuan Province，School of Medicine，University of Electronic Science and Technology of China，Chengdu 610072，China
- Publication Type:Journal Article
- Keywords:
key monitoring drugs;
reasonable drug use;
management standards;
clinical pharmacist
- From:
China Pharmacy
2023;34(19):2305-2310
- CountryChina
- Language:Chinese
-
Abstract:
At present， there is a lack of unified and standardized management for the rational use of national key monitoring drugs. According to the relevant requirements of the state， based on the relevant literature published at home and abroad in recent years and combined with the management practice of many medical institutions across the country on the national key monitoring drugs， in order to make the national key monitoring drugs more reasonable use and standardized management in medical institutions at all levels， the Clinical Pharmacy Branch of the Chinese Medical Association， the Pharmaceutical Epidemiology Special Committee of the Chinese Pharmaceutical Association and the Pharmaceutical Epidemiology Special Committee of the Sichuan Pharmaceutical Association organized experts to fully discuss， and to form this management standard. This standard mainly provides relevant opinions and suggestions on the basic principles of rational use of key monitoring drugs and the regulatory measures for key monitoring drugs， especially on how to strengthen the pharmaceutical management and use management of key monitoring drugs， further promoting the standardized use of key monitoring drugs.
